Literature DB >> 17888412

Angiotensin II increases evoked release at the frog neuromuscular junction through a receptor sensitive to A779.

Fernando Augusto Oliveira1, Priscila Elisa Silveira, Miguel José Lopes, Christopher Kushmerick, Lígia Araujo Naves.   

Abstract

Receptor mediated presynaptic modulation is a ubiquitous mechanism involved in synaptic plasticity. Here we show that angiotensin II increased quantal content at the frog neuromuscular junction. This presynaptic effect of angiotensin II was insensitive to losartan and PD123319, but was antagonized by a more potent partial agonist of the amphibian angiotensin receptor, L162313. In addition, A779, a blocker of the angiotensin-[1-7] receptor, also abolished the effect of angiotensin II. These results indicate that the effect of angiotensin II on evoked release is mediated through an angiotensin receptor. L162313 alone increased quantal content, and A779 also antagonized this effect of L162313. We conclude that the neuromuscular junction possesses angiotensin receptors involved in presynaptic modulation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17888412     DOI: 10.1016/j.brainres.2007.06.013

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

1.  Intraneuronal angiotensinergic system in rat and human dorsal root ganglia.

Authors:  Jaspal Patil; Alexander Schwab; Juerg Nussberger; Thomas Schaffner; Juan M Saavedra; Hans Imboden
Journal:  Regul Pept       Date:  2010-03-24

2.  Type-1 angiotensin receptors are expressed and transported in motor and sensory axons of rat sciatic nerves.

Authors:  Hui Tang; Jaroslav Pavel; Juan M Saavedra; Stephen Brimijoin
Journal:  Neuropeptides       Date:  2009-02-23       Impact factor: 3.286

3.  Reflex erection in the rat: reciprocal interplay between hemodynamic and somatic events.

Authors:  Alexander Andreev-Andrievskiy; Evgeniia Lagereva; Anfisa Popova
Journal:  BMC Urol       Date:  2018-05-08       Impact factor: 2.264

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.